CuraVac: Clinical Trials

2 trials sponsored by CuraVac, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 withdrawn. 2 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Withdrawn 1
Phase 11Completed 1
Phase 31Withdrawn 1

Follow CuraVac: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate the Efficacy of CV-MG01 (Myasterix) in Myasthenia Gravis
CV-MG01, Placebo - Myasthenia Gravis, Generalized
Phase 2 / Phase 3WithdrawnCuraVac2018-07-012018-05-30
Safety, Tolerability and Immunogenic Response of CV-MG01 in Patients With Myasthenia Gravis
CV-MG01, Placebo - Myasthenia Gravis
Phase 1 / Phase 2CompletedCuraVac242016-03-012019-01-28

Conditions studied

Myasthenia Gravis (2)

Countries

Belgium (2)

Top investigators

Rudy Mercelis, MD, PhD (2)

NIH funding

2015 (1), 2017 (1)